Idiopathic Pulmonary Fibrosis Clinical Trials

577 clinical trials for Idiopathic Pulmonary Fibrosis across international registries, including 92 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers. — RECRUITING · PHASE1
• A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE2
• Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study — RECRUITING
• Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE1
• Dose-Escalation Study of Artesunate Patients With IPF — RECRUITING · PHASE1
• WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF) — RECRUITING · PHASE2
• Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE2
• AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF — RECRUITING · PHASE2
• An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) — RECRUITING · PHASE2
• A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast — RECRUITING · PHASE3
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease — RECRUITING · PHASE3
• A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment — RECRUITING · PHASE2
• H01 in Adults With Interstitial Lung Disease (The SOLIS Study) — RECRUITING · PHASE2
• A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE3
• Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE2
• Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease — RECRUITING
• A Phase 2a Multicenter Platform Study of Investigational Products for the Treatment of Adult Subjects with Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE2
• Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF) — RECRUITING · PHASE3
• Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia — RECRUITING · NA
• A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE2
• Interstitial Lung Disease Research Unit Biobank — RECRUITING
• Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets — RECRUITING · PHASE3
• Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF) — RECRUITING · NA
• Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial — RECRUITING · NA
• The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study — RECRUITING
• A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. — RECRUITING · PHASE2
• A Study of the Natural Progression of Interstitial Lung Disease (ILD) — RECRUITING
• Skeletal Muscle Function in Interstitial Lung Disease — RECRUITING · NA
• A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants — RECRUITING · PHASE1
• Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis — RECRUITING · NA
• Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE2
• Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease — RECRUITING · PHASE2
• Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF — RECRUITING · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIAL OF THE EFFICACY AND SAFETY OF MNKD-201 (NINTEDANIB DRY POWDER INHALATION) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS FOLLOWED BY AN OPEN-LABEL EXTENSION — RECRUITING · PHASE2
• Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial — RECRUITING · NA
• Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE2
• Validation of the C-mo System - Cough Monitoring — RECRUITING · NA
• Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE3
• Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. — RECRUITING · NA
• A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) — RECRUITING · PHASE3
• Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) — RECRUITING · PHASE2
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males — RECRUITING · PHASE1
• A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis — RECRUITING · PHASE2
• Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF) — RECRUITING
• Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure — RECRUITING · PHASE1
• A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications — RECRUITING
• Mechanisms of Familial Pulmonary Fibrosis — RECRUITING
• Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole — RECRUITING · PHASE3
• IDIOPATHIC PULMONARY FIBROSIS: A PHASE 2A PLATFORM STUDY OF INVESTIGATIONAL PRODUCTS FOR THE TREATMENT OF ADULT SUBJECTS — RECRUITING · PHASE2
• SB17170 Phase 2 Trial in IPF Patients — RECRUITING · PHASE2

Refine this search